Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Department of Medicine, Imperial College, London, UK.
Eur J Cardiothorac Surg. 2018 Mar 1;53(3):560-568. doi: 10.1093/ejcts/ezx387.
OBJECTIVES: Bicuspid aortic valve (BAV) is the most common congenital valvular abnormality and frequently presents with accelerated calcific aortic valve disease, requiring aortic valve replacement (AVR) and thoracic aortic aneurysm and dissection. Supporting evidence for Association Guidelines of aortic dimensions for aortic resection is sparse. We sought to determine whether concurrent repair of dilated or aneurysmal aortic disease during AVR in patients with BAV substantially improves morbidity and mortality outcomes. METHODS: Mortality and reoperation outcomes of 1301 adults with BAV and dilated aorta undergoing AVR-only surgery were compared to patients undergoing AVR with aortic resection (AVR-AR) using Cox proportional hazards modelling and patient matching. RESULTS: Clinically important differences in patient characteristics, aortic valve function and aortic dimensions were identified between cohorts. Event rates were low, with rates of reoperation and death within 1 year of only 1.8% and 5.4%, respectively, and no aortic dissection observed during follow-up. There were no significant differences in reoperation or mortality outcomes between the AVR-only and AVR-AR cohorts. Age, aortic dimension or a combination thereof was not associated with better or worse outcomes after each AVR-AR compared with AVR. CONCLUSIONS: We conclude AVR-only and AVR-AR surgery have low morbidity and mortality and have utility over a wide range of age and aortic sizes. Our results do not provide support for the 45-mm aortic dimension recommended in the current guidelines for aortic resection while performing AVR or any other specific dimension.
目的:二叶式主动脉瓣(BAV)是最常见的先天性瓣膜异常,常伴有加速性主动脉瓣钙化性疾病,需要进行主动脉瓣置换术(AVR)和胸主动脉瘤及夹层。支持行 AVR 时切除主动脉的协会指南中关于主动脉尺寸的证据很少。我们旨在确定在 BAV 患者中进行 AVR 时同时修复扩张或动脉瘤样主动脉疾病是否能显著改善发病率和死亡率结局。
方法:采用 Cox 比例风险模型和患者匹配比较了 1301 例接受单纯 AVR 手术的 BAV 伴扩张主动脉患者与接受 AVR 加主动脉切除术(AVR-AR)患者的死亡率和再次手术结局。
结果:两组患者的临床特征、主动脉瓣功能和主动脉尺寸存在显著差异。事件发生率较低,1 年内再次手术和死亡的发生率分别为 1.8%和 5.4%,随访期间未发生主动脉夹层。AVR-AR 组与单纯 AVR 组的再次手术或死亡率结局无显著差异。年龄、主动脉尺寸或两者的组合与每次 AVR-AR 后与 AVR 相比的预后更好或更差无关。
结论:我们得出结论,单纯 AVR 和 AVR-AR 手术具有较低的发病率和死亡率,适用于广泛的年龄和主动脉大小。我们的结果不支持当前指南中建议在进行 AVR 或任何其他特定尺寸时切除主动脉的 45mm 主动脉尺寸。
Eur J Cardiothorac Surg. 2018-3-1
Interact Cardiovasc Thorac Surg. 2016-4
Arch Cardiovasc Dis. 2019-2-14
J Thorac Cardiovasc Surg. 2014-11
Eur J Cardiothorac Surg. 2014-5
J Thorac Cardiovasc Surg. 2012-12-13
J Am Heart Assoc. 2025-4-15
Cardiol Res Pract. 2022-9-10
J Cardiothorac Surg. 2022-5-7
Front Physiol. 2021-7-6
J Am Coll Cardiol. 2016-9-13
Interact Cardiovasc Thorac Surg. 2016-4
J Thorac Cardiovasc Surg. 2014-6
J Am Coll Cardiol. 2014-2-5